Market revenue in 2022 | USD 172.0 million |
Market revenue in 2030 | USD 242.7 million |
Growth rate | 4.4% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.28% in 2022. Horizon Databook has segmented the Canada orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
The Canada orthopedic regenerative surgical products market accounted for 9.82% market share in 2021. This growth can be attributed to the growing geriatric population and rising incidence of degenerative arthritis, which affects protective cartilage in the hips and knees. This has led to increase in the demand for surgeries.
In addition, market players are designing and introducing products to deliver innovative solutions. This is expected to support market growth. For instance, Ortho Regenerative Technologies Inc., based in country, is an emerging orthobiologics corporation devoted to the development of innovative therapeutic tissue repair technologies to dramatically advance the success rate of orthopedic musculoskeletal surgeries.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into Canada orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account